ESC 365 - The burden of CV disease and the value of cardiac biomarkers in the post-COVID19 era.

Open Access

The burden of CV disease and the value of cardiac biomarkers in the post-COVID19 era.

Session: Prevention of cardiovascular diseases in the post-COVID19 era

Topic: Prevention

Speaker: Professor N. Sattar (Glasgow, GB)

Sponsored by Abbott

Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

42 presentations

2 followers

3 more presentations in this session

Welcome and introduction.

Speaker: Professor W. Koenig (Munich, DE)

Setting troponin as a key risk stratification tool in CVD prevention: practical recommendations.

Speaker: Associate Professor D. Farmakis (Athens, GR)

ACR and lipid point-of-care testing as tools for CVD prediction and management.

Speaker: Professor O. Schnell (Munich, DE)

Access the full session

Prevention of cardiovascular diseases in the post-COVID19 era

Speakers: Professor N. Sattar, Professor W. Koenig, Associate Professor D. Farmakis, Professor O. Schnell

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by